“When we treat TB, we're not treating one disease, but really several manifestations of that disease,” says Stewart Cole, Professor and Chair of Microbial Pathogenesis and Director of the ...

A huge and much-anticipated phase 3 trial of a new tuberculosis vaccine has kicked off in South Africa, raising hopes of a better way to tackle a disease that – despite being treatable – still ...